SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Payoneer’s turnaround story: Stock soars on back of strong earnings and raised outlook

How Musk’s X account floods feeds with pro-Trump messages and election misinformation

Harris vs. Trump: Competing visions for America's economic future

Is ChatGPT about to upend Google’s long-reigning search dominance?

Buzz

Most popular

Daily

Weekly

1

Wiz eyeing Dazz acquisition in deal worth hundreds of millions

2

Four years and billions later, Intel’s Habana Labs is still searching for success amid layoffs

3

Intel's workforce questions its future amid layoffs and shrinking benefits

4

From Intel to Meta: How high-tech giants are rethinking employee perks

5

Sequoia-backed Decart raises $21M in Seed funding to pioneer scalable, cost-efficient GenAI

Neuorology

2 stories about Neuorology

NeuraLight team

NeuraLight secures $25 million Series A to develop precision medicine for neurological diseases

24.05.22|Meir Orbach

The company leverages oculometric data and uses computer vision and smartphones to measure the progression of neurological disorders such as Alzheimer’s, Parkinson’s, MS, and ALS

מיכה ברקסטון NeuraLight

How can startups leverage controversial FDA approval for Alzheimer’s drug?

17.06.21|Dr. Micha Breakstone

The decision to approve Biogen's Alzheimer’s drug signifies a watershed moment for neurology, highlighting an unprecedented opportunity for neurology-focused startups